Specifically, while anti-TNFα therapy is an effective treatment for Inflammatory Bowel Disease (IBD) and rheumatoid arthritis (RA), it paradoxically induces exacerbations in patients with MS30,31. Here, TNF is linked to inflammatory bowel disease.